Glyburide

insulin ; Homo sapiens







292 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
251 6439409 Glyburide (DiaBeta): a new second-generation hypoglycemic agent. 1984 3
252 6136627 Somatostatinoma syndrome. Clinical, morphological and metabolic features and therapeutic aspects. 1983 Jul 15 1
253 6401923 Insulin resistance in noninsulin-dependent diabetes mellitus: impact of sulfonylurea agents in vivo and in vitro. 1983 Jan 17 5
254 6413265 The effect of long-term glibenclamide treatment on glucose tolerance, insulin secretion and serum lipids in subjects with impaired glucose tolerance. 1983 May-Jun 3
255 6415086 The effect of glibenclamide on insulin receptors in normal man: comparative studies of insulin binding to monocytes and erythrocytes. 1983 Dec 5
256 6800910 Comparison of diurnal serum insulin levels during short term treatments with sulfonylurea and with insulin in non-insulin dependent diabetes. 1982 Jan 1
257 6805141 [Effect of glibenclamide therapy on carbohydrate and lipid metabolism and insulin secretion in patients with glucose tolerance disorders : a 5-year study]. 1981 Dec 1 1
258 7029541 Insulin immunoreactive sites demonstrated in the Golgi apparatus of pancreatic B cells. 1981 Sep 2
259 6772676 Direct in vitro effect of a sulfonylurea to increase human fibroblast insulin receptors. 1980 Sep 3
260 6776759 Stimulation of residual insulin secretion by glibenclamide in insulin dependent diabetics. 1980 Nov 2
261 6776763 Diurnal pattern of plasma insulin and blood glucose during glibenclamide and glipizide therapy in elderly diabetics. 1980 2
262 6777211 The effect of glibenclamide on the glucose and insulin profile in maturity onset diabetics following both acute and long term treatment. 1980 Sep 1
263 6778077 Effects of glucagon and pentagastrin on glibenclamide-induced insulin release. 1980 Jul 2
264 6778079 Comparative single-dose kinetics and effects of four sulfonylureas in healthy volunteers. 1980 1
265 106617 Increased insulin sensitivity and cellular insulin binding in obese diabetics following treatment with glibenclamide. 1979 Mar 10
266 111449 Effect of two sulphonylureas on the dose kinetics of glucose-induced insulin release in normal and diabetic subjects. 1979 Jun 4
267 115730 The effect of glibenclamide treatment on the insulin and glucagon responses to oral glucose and galactose in maturity onset diabetics. 1979 Sep 2
268 101402 Comparative effects of two doses of glibenclamide upon metabolic rhythms in maturity-onset diabetics. 1978 Sep 1
269 413023 Glucagon and growth hormone secretion in insulin-treated diabetics: effects of added sulfonylureas. 1978 Jan 1
270 415745 [Insulin and pro-insulin secretion following intravenous administration of tolbutamide, glisoxepide and glibenclamide]. 1978 2
271 403065 [Attempted suicide using glibenclamide:course of glucose, insulin, glibenclamide and C-peptide blood levels]. 1977 Apr 15 1
272 404205 Comparative effects of phenformin, metformin and glibenclamide on metabolic rhythms in maturity-onset diabetics. 1977 Apr 1
273 410692 Potentiation of glibenclamide-induced insulin release by calcium infusion. 1977 Aug 3
274 411723 Repeated blood glucose and plasma insulin levels in normal volunteer subjects receiving isocaloric meals, before and after chlorpropamide and glibenclamide. 1977 Sep 3
275 12072 Studies on the dynamics and mechanism of glibenclamide-induced insulin secretion. 1976 Nov 5
276 814956 Diet and oral antidiabetic drugs and plasma sugar and insulin levels in patients with maturity-onset diabetes mellitus. 1976 Feb 28 1
277 829387 [Blood sugar and serum insulin levels with reference to the glibenclamide concentration in suicidal glibenclamide poisoning. Case report]. 1976 2
278 804684 [Daily curves of blood sugar and serum insulin after treatment with various combinations of glibenclamide and phenformin]. 1975 Mar 14 1
279 805520 Increased disaccharidase activity in human diabetics. 1975 Jun 1
280 811925 [Clinical investigations of the effect of tolbutamide and glibenclamide on pancreatic glucagon secretion (author's transl)]. 1975 Jun 15 1
281 4197367 [Plasma insulin and glucose levels in diabetics treated with glibenclamide and chlorporpamide]. 1973 Jan-Feb 1
282 4201174 The pancreatic beta-cell recognition of insulin secretagogues. Inhibitory effects of a membrane probe on the islet uptake and insulin-releasing action of glibenclamide. 1973 Aug 15 1
283 4353086 The mode of action of adenosine 3':5'-cyclic monophosphate in mammalian islets of Langerhans. Effects of insulin secretagogues on islet-cell protein kinase activity. 1973 May 1
284 4198966 [Extrapancreatic effects of sulfonylurea compounds. IV. Increase of the effect of insulin due to tolbutamide, glibornuride, and glibenclamide in vitro]. 1972 Dec 1
285 4622788 Profile of insulin release due to intrapancreatic glyburide infusion. 1972 Apr 1
286 5005528 [Is the increase of hypoglycemic reactions during glibenclamide therapy due to a substance-specific stronger stimulation of the insulin secretion?]. 1971 1
287 5005530 [Behavior of serum insulin in the double intravenous glucose tolerance test in diabetics before and during glibenclamide therapy]. 1971 1
288 4107054 [In-vitro changes of the serum binding capacity for 131 I-insulin under tolbutamide and glybenclamide in normal persons, in juvenile and senile diabetes, as well as in insulin resistance]. 1970 Apr 1 1
289 5434298 Effects of glycodiazin and glybenclamide upon insulin secretion in vitro. 1970 Jan 1
290 5440469 [Blood sugar and plasma insulin levels in children following the oral administration of glybenclamide (HB 419)]. 1970 1
291 5526611 Clinical and metabolic study in diabetic patients treated with glibenclamide. 1970 Jun 6 1
292 5533294 Plasma insulin and metabolic study on diabetes treated with glibenclamide. 1970 Dec 1